MIAMI, Dec. 9, 2014 (GLOBE NEWSWIRE) -- Sanomedics International Holdings, Inc. (OTCQB:SIMH) ("Sanomedics" or the "Company"), a medical technology holding company that focuses on providing game changing products, services and ideas, announced today that the Company's Thermomedics, Inc. division, makers of the world's leading TouchFree™ Clinical Thermometer, Caregiver®, has signed a comprehensive distribution agreement with Henry Schein, Inc. (Nasdaq: HSIC ) ("Schein").
Schein is the world's largest provider of healthcare products and services to office-based dental, animal health, and medical practices with operations and affiliates in 28 countries and sales of over $9.6 billion in 2013. They recently came to an agreement with Cardinal Health, Inc. in which the physician office sales team and physician office distribution business of Cardinal Health's Medical segment, with annual sales of more than $300 million, will be transitioned into Henry Schein's Medical Group, servicing the medical product needs of more than 25,000 physician office customer locations and approximately 200 employees.
Keith Houlihan, President and founder of Sanomedics, commented, "The addition of Schein's premier sales and service organization for Alternate Care sites will perfectly complement our existing national sales organizations for Acute Care facilities. We expect that this distribution agreement will create immediate sales and service opportunities and increase our penetration into the fast-growing healthcare providers market."
Ron Benincasa, VP Sales and Marketing for Thermomedics, commented, "Sales of our TouchFree clinical thermometer, Caregiver, are continuing to soar based upon the demand from new infection control protocols being implemented at many of the world's hospitals and healthcare facilities, with an emphasis on reduced contagion. Our Caregiver thermometer provides medical professionals, especially in urgent situations treating highly infectious diseases such as Ebola, Flu, and other Viral and Bacterial entities, with a TouchFree™ thermometer that will help minimize contact and enhance infection control."
About Sanomedics International Holdings, Inc.
Sanomedics International Holdings, Inc. (OTCQB:SIMH) is a medical technology holding company that focuses on game changing products, services and ideas -- a place where physicians, entrepreneurs, and medical companies can work together to drive innovative technologies through concept, development, and ultimately commercialization. Sanomedics plans to grow existing business organically and through strategic acquisitions specifically relating to healthcare technology and services.
Sign up for Sanomedics email news alert system today at: http://ir.stockpr.com/sanomedics/email-alerts .
Follow us on Twitter @Sanomedics
About Henry Schein, Inc.
Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500® Company and a member of the NASDAQ 100® Index, Henry Schein employs more than 17,000 Team Schein Members and serves more than 800,000 customers.
Forward Looking Statements
Statements in this press release regarding Sanomedics that are not historical facts are forward-looking statements and are subject to risks and uncertainties that could cause actual future events or results to differ materially from such statements. Any such forward-looking statements, including, but not limited to, financial guidance are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not directly or exclusively relate to historical facts. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "could," "would," "expects," "plans," "anticipates," "believes," "estimates," "projects," "forecasts," "predicts," "potential," or the negative of those terms, and similar expressions and comparable terminology. These include, but are not limited to, statements relating to future events or our future financial and operating results, plans, objectives, expectations and intentions. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these expectations may not be achieved. Forward-looking statements represent our intentions, plans, expectations, assumptions and beliefs about future events and are subject to known and unknown risks, uncertainties and other factors outside of our control that could cause our actual results, performance or achievement to differ materially from those expressed or implied by these forward-looking statements.
Keith Houlihan Sanomedics International Holdings, Inc.
